Management of Acute Asthma
Immediately administer high-flow oxygen (40-60%) to maintain SaO₂ >92%, nebulized salbutamol 5 mg (or terbutaline 10 mg) via oxygen-driven nebulizer, and systemic corticosteroids (prednisolone 30-60 mg orally or hydrocortisone 200 mg IV) within the first few minutes of presentation. 1
Initial Severity Assessment
Rapidly categorize severity using objective criteria to guide treatment intensity:
Severe Asthma Features:
- Unable to complete sentences in one breath 2, 1
- Respiratory rate >25 breaths/min 2, 1
- Heart rate >110 beats/min 2, 1
- Peak expiratory flow (PEF) <50% of predicted or personal best 2, 1
Life-Threatening Features (requiring immediate ICU consideration):
- PEF <33% of predicted or best 2, 1
- Silent chest on auscultation, cyanosis, or weak respiratory effort 2, 1
- Bradycardia, hypotension, or altered mental status 2, 1
- Exhaustion, confusion, or coma 2
- PaCO₂ ≥42 mmHg or severe hypoxia (PaO₂ <60 mmHg despite oxygen) 2, 1
Critical Pitfall: Patients with severe or life-threatening attacks may not appear distressed initially—the presence of any single life-threatening feature should trigger maximum intensity treatment. 2
Immediate First-Line Treatment (First 5 Minutes)
Administer all three components simultaneously:
1. Oxygen Therapy:
- High-flow oxygen 40-60% via face mask 2, 1
- Target SaO₂ >92% (>95% in pregnant patients or those with cardiac disease) 1
- Important: CO₂ retention is NOT aggravated by oxygen therapy in asthma 2
2. Nebulized Beta-Agonist:
- Salbutamol 5 mg OR terbutaline 10 mg via oxygen-driven nebulizer 2, 1, 3
- Deliver over 5-15 minutes 3
- For children: same dose if weight ≥15 kg; half dose if <15 kg 2
3. Systemic Corticosteroids:
- Prednisolone 30-60 mg orally (adults) 2, 1
- OR hydrocortisone 200 mg IV if unable to take oral medication 2, 1
- For children: prednisolone 1-2 mg/kg (maximum 40 mg) 2, 1
- Critical: Administer immediately—clinical benefits require 6-12 hours to manifest 4
4. Additional Treatment for Life-Threatening Features:
- Add ipratropium 0.5 mg to the nebulized beta-agonist 2, 1
- Give IV aminophylline 250 mg over 20 minutes OR salbutamol/terbutaline 250 µg IV over 10 minutes 2
- Caution: Do NOT give bolus aminophylline to patients already taking oral theophyllines 2
- Obtain chest radiograph to exclude pneumothorax 2
Reassessment at 15-30 Minutes
Measure PEF and reassess clinical status after initial treatment 1:
If Patient is Improving:
- Continue 40-60% oxygen 2
- Continue prednisolone 30-60 mg daily or IV hydrocortisone 200 mg every 6 hours 2
- Nebulized beta-agonist every 4 hours 2
If Patient is NOT Improving:
- Continue oxygen and steroids 2
- Increase nebulized beta-agonist frequency to every 15-30 minutes 2
- Add ipratropium 0.5 mg to nebulizer if not already given, repeat every 6 hours 2
- Consider IV magnesium sulfate 2 g over 20 minutes for severe exacerbations not responding after 1 hour 1, 5
If Patient is Still NOT Improving:
- Aminophylline infusion: 750 mg/24 hours (small patient) to 1500 mg/24 hours (large patient) 2
- Monitor blood concentrations if continued >24 hours 2
- Salbutamol or terbutaline infusion as alternative to aminophylline 2
Critical Pitfalls to Avoid
Never administer sedatives of any kind during an acute asthma exacerbation—this can precipitate respiratory failure and increases mortality risk. 2, 1, 3
Do not underestimate severity based on initial presentation—patients can deteriorate rapidly and may not exhibit distress despite severe obstruction. 2, 1
Do not delay corticosteroids—waiting for response to bronchodilators before giving steroids is a common error that worsens outcomes. 1, 4
Monitoring During Treatment
Continuous monitoring includes:
- Pulse oximetry to maintain SaO₂ >92% 1
- PEF measurement before and after each nebulization 1
- Respiratory rate and heart rate every 15-30 minutes initially 1
- Arterial blood gas if PEF <25% predicted, severe distress, or suspected hypoventilation 1
Criteria for Hospital Admission
Admit to hospital if:
- Any life-threatening features present 2
- Features of severe asthma persist after initial treatment, especially PEF <33% 2
- PEF remains <50-75% after treatment 2
- Recent nocturnal symptoms or previous severe attacks 1
ICU Transfer Criteria
Transfer to ICU accompanied by a physician prepared to intubate if:
- Deteriorating PEF despite maximal therapy 2
- Worsening or persistent hypoxia or rising PaCO₂ 2
- Exhaustion, feeble respirations, confusion, or drowsiness 2, 1
- Inability to speak or worsening mental status 1
Intubation Consideration: When intubation becomes necessary, it should not be attempted until the most expert available physician (ideally an anesthetist) is present. 1
Discharge Criteria
Patients may be discharged when:
- Stable on discharge medication for 24 hours 2
- PEF >75% of predicted or best 2
- PEF diurnal variability <25% 2
- Inhaler technique checked and recorded 2
At discharge, ensure patient has: